Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Stoke Therapeutics
STOK
$2.02B
| $3.33M | ﹤0.01% |
117,404
+9,508
| +9% | +$239K |
|
2827
Spok Holdings
SPOK
$230M
| $3.32M | ﹤0.01% |
271,181
-2,131
| -0.8% | -$25.2K |
|
2828
Ooma
OOMA
$574M
| $3.31M | ﹤0.01% |
250,310
+25,036
| +11% | +$305K |
|
|
KALV
2829
DELISTED
KalVista Pharmaceuticals
KALV
| $3.31M | ﹤0.01% |
185,769
+7,248
| +4% | +$94.6K |
|
|
GHL
2830
DELISTED
Greenhill & Co., Inc.
GHL
| $3.3M | ﹤0.01% |
193,345
-18,585
| -9% | -$302K |
|
2831
United States Lime & Minerals
USLM
$3.37B
| $3.3M | ﹤0.01% |
182,715
+3,665
| +2% | +$64.4K |
|
2832
Evolus
EOLS
$530M
| $3.3M | ﹤0.01% |
270,930
+40,286
| +17% | +$568K |
|
2833
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.68B
| $3.29M | ﹤0.01% |
85,018
+715
| +0.8% | +$27.7K |
|
|
AKCA
2834
DELISTED
Akcea Therapeutics Inc
AKCA
| $3.28M | ﹤0.01% |
193,686
-2,001
| -1% | -$37.2K |
|
2835
Vera Bradley
VRA
$94.7M
| $3.27M | ﹤0.01% |
277,533
-8,680
| -3% | -$96.2K |
|
|
HALL
2836
DELISTED
Hallmark Financial Services, Inc.
HALL
| $3.27M | ﹤0.01% |
18,611
-350
| -2% | -$64K |
|
2837
Puma Biotechnology
PBYI
$450M
| $3.27M | ﹤0.01% |
373,441
-14,072
| -4% | -$116K |
|
2838
Farmers & Merchants Bancorp
FMAO
$486M
| $3.26M | ﹤0.01% |
108,113
+1,115
| +1% | +$29.5K |
|
2839
Amalgamated Financial
AMAL
$1.53B
| $3.25M | ﹤0.01% |
167,183
+7,667
| +5% | +$141K |
|
|
MIME
2840
DELISTED
Mimecast Limited
MIME
| $3.25M | ﹤0.01% |
74,836
+2,610
| +4% | +$109K |
|
|
CALA
2841
DELISTED
Calithera Biosciences, Inc
CALA
| $3.25M | ﹤0.01% |
28,411
+1,694
| +6% | +$127K |
|
2842
Transmedics
TMDX
$3.11B
| $3.24M | ﹤0.01% |
170,518
+72,913
| +75% | +$1.34M |
|
2843
Gold Fields
GFI
$35.4B
| $3.24M | ﹤0.01% |
490,641
-11,056
| -2% | -$62.7K |
|
2844
American Coastal Insurance
ACIC
$461M
| $3.23M | ﹤0.01% |
256,405
+305
| +0.1% | +$3.88K |
|
|
SMMF
2845
DELISTED
Summit Financial Group, Inc.
SMMF
| $3.22M | ﹤0.01% |
118,737
-2,993
| -2% | -$78.9K |
|
2846
Intrepid Potash
IPI
$484M
| $3.21M | ﹤0.01% |
118,522
-2,945
| -2% | -$80K |
|
|
AMRN
2847
Amarin Corp
AMRN
$299M
| $3.21M | ﹤0.01% |
7,480
+83
| +1% | +$31.5K |
|
2848
Angi Inc
ANGI
$196M
| $3.2M | ﹤0.01% |
37,807
+73
| +0.2% | +$5.45K |
|
2849
Green Brick Partners
GRBK
$3.04B
| $3.19M | ﹤0.01% |
278,309
-2,094
| -0.7% | -$22.9K |
|
|
IHC
2850
DELISTED
Independence Holding Company
IHC
| $3.19M | ﹤0.01% |
75,748
-2,169
| -3% | -$87.1K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.